In the News
Keep up to date with the latest news articles from around the world.
Articles represent the views of their authors and not ME/CFS SA. Always seek advice from a registered health practitioner before changing your care plan.
29 November, 2024
Welsh National Opera Expands Wellness With WNO As Rehabilitation Service
The Welsh National Opera arts and health program, “Wellness with WNO,” has announced that it will be expanding as a rehabilitation service for other health conditions. The program which was launched during COVID will include people living with persistent pain and myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS).
29 November, 2024
A Hospital In New Zealand Discharged A Young Severe ME/CFS Patient To A Care Home For Pensioners
A hospital in New Zealand discharged a 34-year-old severe myalgic encephalomyelitis (ME/CFS) patient to a care home for pensioners. There, staff were hugely ill-equipped for her care and the environment utterly inappropriate for her condition.
29 November, 2024
Discriminating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome And Comorbid Conditions Using Metabolomics In UK Biobank
Diagnosing complex illnesses like Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is complicated due to the diverse symptomology and presence of comorbid conditions. ME/CFS patients often present with multiple health issues, therefore, incorporating comorbidities into research can provide a more accurate understanding of the condition’s symptomatology and severity, to better reflect real-life patient experiences.
28 November, 2024
10-Year-Old Fylde Girl Wins National Award For Caring For Mum
A 10-year-old girl from St Annes, Lancashire, has won a national award in recognition of the care she provides to her disabled mother and brother. Bryanna Hewitson was awarded ‘Family Carer of the Year’ in the Sense Awards, run by the disability charity Sense.
28 November, 2024
Claire Nielsen: Fighting Fibromyalgia
Columnist Claire Nielsen shares her personal experience with fibromyalgia and how an anti-inflammatory diet is key.
28 November, 2024
Towards A Cure For Long COVID: The Strengthening Case For Persistently Replicating SARS-CoV-2 As A Driver Of Post-Acute Sequelae Of COVID-19
New insights into post-acute sequelae of coronavirus disease 2019 (PASC) or long COVID are emerging at great speed. Proposed mechanisms driving long COVID include the overlapping pathologies of immune and inflammatory dysregulation, microbiota dysbiosis, autoimmunity, endothelial dysfunction, abnormal neurological signalling, reactivation of endogenous herpesviruses, and persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this commentary, we describe some of these advances that indicate that long COVID may be driven by “long infection” and that persistent replicating SARS-CoV-2 may be the potentially mechanistically unifying driver for long COVID.
27 November, 2024
Electrical Nerve Stimulation Eases Long COVID Pain And Fatigue, Study Finds
Wearable TENS system 'offered immediate, on-demand relief,' say researchers.
27 November, 2024
From Pop Star To Poet For Hit-Maker Marina
CHART-topping singer-songwriter Marina Diamandis has published her first book of poetry and promoted it with a book tour in the UK and the US. The book of poetry was born out of her recovery from a long period of chronic fatigue syndrome, an "invisible" illness that was finally diagnosed in 2023, which allowed her to start the 'healing' process.
27 November, 2024
Towards A Cure For Long COVID: The Strengthening Case For Persistently Replicating SARS‐CoV‐2 As A Driver Of Post‐Acute Sequelae Of COVID‐19
New insights into post‐acute sequelae of coronavirus disease 2019 (PASC) or long COVID are emerging at great speed. Proposed mechanisms driving long COVID include the overlapping pathologies of immune and inflammatory dysregulation, microbiota dysbiosis, autoimmunity, endothelial dysfunction, abnormal neurological signalling, reactivation of endogenous herpesviruses, and persistence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). In this commentary, we describe some of these advances that indicate that long COVID may be driven by “long infection” and that persistent replicating SARS‐CoV‐2 may be the potentially mechanistically unifying driver for long COVID.
26 November, 2024
Radio Electric Asymmetric Conveyer (REAC) Biomodulation For Chronic Pain And Functional Improvement In Rheumatoid Arthritis, Lipedema, And Fibromyalgia: A Case Study On Anti-Inflammatory, Circulatory, And Metabolic Optimization
This case report explores the use of radio electric asymmetric conveyor (REAC) technology for chronic pain management, functional limitations, and metabolic dysfunction in a 67-year-old female with rheumatoid arthritis, advanced lipedema, and fibromyalgia. The patient underwent three REAC protocols: Anti-cellulite treatment (ACT), circulatory optimization (CO), and metabolic optimization (MO), each targeting distinct pathophysiological aspects. The ACT protocol primarily addressed chronic inflammation contributing to pain and tissue dysfunction associated with lipedema. The CO protocol enhanced joint mobility by improving systemic and local blood flow, relieving joint stiffness due to rheumatoid arthritis. The MO protocol focused on metabolic restoration to counter chronic fatigue linked to lipedema and fibromyalgia.
